Skip to content

How rare is Paget's disease? A detailed look at prevalence

4 min read

While it's the second most common bone disorder after osteoporosis in older adults, the global prevalence of Paget's disease has decreased significantly in recent decades. This shift and the disease's varied occurrence make the question, "How rare is Paget's disease?" surprisingly complex.

Quick Summary

The rarity of Paget's disease depends heavily on geographic location, age, and ancestry, with prevalence decreasing globally despite remaining more common in older, Northern European populations than previously documented.

Key Points

  • Prevalence Varies: Paget's disease is not universally rare, with prevalence differing significantly based on age, ancestry, and geographic location.

  • More Common in Older Adults: The disease is most common in people over 50 and especially those over 80, with a history of being more prevalent in populations of Western European heritage.

  • Declining Incidence: The prevalence and severity of Paget's disease have been decreasing in many countries since the 1970s, suggesting a change in environmental factors.

  • Often Asymptomatic: A large number of individuals with Paget's disease have no symptoms and are diagnosed incidentally through unrelated tests.

  • Distinct from Breast Cancer: It is crucial to differentiate Paget's disease of bone from Paget's disease of the breast, which is an unrelated and very rare form of cancer.

  • Genetic and Environmental Roots: The cause is unknown, but a combination of genetic factors and environmental triggers (like potential viral exposure) is suspected.

In This Article

Prevalence depends on age, genetics, and geography

Classic Paget's disease of bone is rarely diagnosed in people under 40, but the incidence increases significantly with age. While the global prevalence has seen a notable decline in recent decades, it is still more common in certain populations than in others. For example, individuals of Western and Northern European descent, particularly from the UK, Australia, and New Zealand, have historically shown higher rates. In contrast, the disease has always been exceedingly rare in Asian and Scandinavian populations.

One significant aspect influencing its perceived rarity is that many cases are asymptomatic, meaning individuals have the disease without experiencing any symptoms. This often leads to an incidental diagnosis during an x-ray or blood test for an unrelated condition, suggesting the actual prevalence might be higher than the number of diagnosed cases. This phenomenon also affects prevalence statistics from earlier decades, where improved diagnostics led to a temporary spike in detected cases before the current decline was observed.

Unpacking the two main types of Paget's disease

It is critical to distinguish between Paget's disease of bone and Paget's disease of the breast, as they are completely different conditions. While the keyword specifically refers to the bone disorder, the name can cause confusion. Paget's disease of the breast is a rare form of breast cancer, affecting the nipple and areola, and is unrelated to the bone disorder that affects bone recycling. The following table highlights the key differences.

Feature Paget's Disease of Bone Paget's Disease of the Breast
Condition Type Metabolic bone disorder Rare form of breast cancer
Affected Area Bones (especially pelvis, spine, skull, legs) Nipple and areola
Pathology Disorganized and rapid bone remodeling Malignant cells on the skin surface
Rarity Prevalence varies significantly by age and geography Very rare, 1-4% of all breast cancers
Related to Aging More common in older adults (50+) Primarily affects women over 50, but can affect men
Cause Unknown; likely genetic and environmental factors Unknown; possibly cancer cells moving from a tumor within the breast

Potential factors behind its changing rarity

While the exact cause of Paget's disease of bone is unknown, a combination of genetic and environmental factors is thought to contribute to its development and varying prevalence. The observed decrease in its incidence and severity over time suggests that environmental triggers may have played a larger role in previous generations. Proposed factors include:

  • Changes in exposure to certain environmental toxins, such as lead.
  • Improved sanitation and changes in lifestyle, which may have reduced exposure to certain viral infections (like paramyxoviruses) linked to the disease.
  • Improvements in overall public health and nutrition, including better dietary intake of calcium and vitamin D.

Genetic predisposition also plays a role, with mutations in genes like SQSTM1 linked to the disease. The presence of these genetic markers, however, does not always guarantee the development of Paget's disease, suggesting that environmental factors act as necessary triggers.

Recognizing the signs and managing the condition

Because many individuals are asymptomatic, it's crucial for healthcare providers to be aware of the disease, especially in at-risk populations. Regular monitoring and early diagnosis can help manage symptoms and prevent complications. Symptoms that do occur are often related to the affected bones.

Common symptoms of Paget's disease

  • Bone pain: The most common symptom, occurring near the affected bone.
  • Enlarged or deformed bones: Such as a bowed leg or enlarged skull.
  • Hearing loss: Can result if the skull is affected and pressure is put on the nerves.
  • Headaches: May also occur from skull involvement.
  • Joint pain and arthritis: Misshapen bones can stress nearby joints.
  • Nerve compression: Affecting the spine can lead to pain, tingling, or weakness in limbs.
  • Warmth over affected areas: Due to increased blood flow to the bone.

Treatment and prognosis

When treatment is necessary, bisphosphonates are the most common medication, helping to slow down abnormal bone turnover. In severe cases, surgery may be required to correct deformities or repair fractures. The prognosis is generally good, with most cases well-managed, although a small percentage of individuals may develop more serious complications.

Conclusion: More variable than rare

So, how rare is Paget's disease? The answer is nuanced. While considered uncommon in the general population, especially globally, its prevalence and impact are far from rare in older adults of specific European descent. Moreover, the long-term decline in incidence suggests a shift in environmental factors. Early identification through routine testing in at-risk groups, including those over 50, remains critical for effective management and preventing complications. Understanding its geographical and demographic variations is key to accurately assessing its rarity and providing proper care. To learn more about metabolic bone disorders, visit the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS): https://www.niams.nih.gov/.

Frequently Asked Questions

While not a common condition globally, the rarity of Paget's disease depends on the population. It's more common in older adults and those of Northern European descent, and less common in Asian or Scandinavian populations.

Yes, research indicates that the incidence and prevalence of Paget's disease have been decreasing in countries where it was once common, like the United Kingdom, since the 1970s. The reasons for this trend are not fully understood but may be related to environmental and lifestyle changes.

It's important to differentiate Paget's disease of bone from Paget's disease of the breast. The bone disorder affects bone remodeling, while the breast condition is a rare cancer affecting the nipple. They are unrelated conditions.

Genetic factors play a significant role in many cases. The disease can run in families, and several genes have been linked to an increased risk. However, it's also believed that environmental factors act as triggers.

In many cases, the disease is diagnosed incidentally during x-rays or blood tests conducted for other reasons. High levels of the enzyme alkaline phosphatase (ALP) in a blood test can be an indicator, and x-rays show characteristic bone changes.

The disease can affect any bone, but it most commonly occurs in the pelvis, spine, skull, and legs.

No. Many people with the condition are asymptomatic or have very mild symptoms. The severity of the disease varies greatly, and in most cases, it can be effectively managed with medication to control its progression and symptoms.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.